SGLT2 inhibitor empagliflozin could be a new treatment for children with type 2 diabetes: lancet

Published Date: 04 Mar 2023

United States: Empagliflozin could be a new treatment option for children and adolescents with type 2 diabetes, with phase 3 clinical trials showing...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Researchers achieve a significant milestone in the management of anemia in chronic lymphocytic leukemia.

2.

Researchers can now forecast how prostate cancer bone metastases will react to radium-223 treatment.

3.

The Kansas Cancer Center awarded two Indian American doctors professorships.

4.

Frontline EGFR/VEGF Inhibition Slows Advanced EGFR-Positive Lung Cancer

5.

Increased Data Support Active Monitoring for Low-Risk Prostate Cancer.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot